Summary:
- This article reports the results of a clinical trial evaluating the safety and efficacy of a new COVID-19 vaccine developed by Moderna.
- The study found that the vaccine was highly effective in preventing COVID-19 infection, with a 94.1% efficacy rate.
- The vaccine was also found to be generally well-tolerated, with no serious safety concerns identified during the trial.